<DOC>
	<DOC>NCT01244659</DOC>
	<brief_summary>Comparison of safety and efficacy of immunosuppressive regiments using tacrolimus from EMS and Prograf® in post renal transplanted patients.</brief_summary>
	<brief_title>A Randomized Study Assess the Safety and Efficacy of Tacrolimus vs Prograf® in Renal Transplantation Treatment</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Immunosuppressive Agents</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<criteria>Age &gt; 18 year old Patient is receiving kidney from live or death donor Kidney donor younger than 65 years old PRA ≤ 30% Negative pregnancy test for women Patient agreement to practice birth control Patient has been fully informed and has given written informed consent HLA identical Patient multiorgan transplant recipient Any pathology or past medical condition that can interfere with this protocol Allergy or intolerance of any study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Tacrolimus</keyword>
	<keyword>Immunosuppressive Agents</keyword>
	<keyword>Kidney transplantation</keyword>
</DOC>